AlzeCure Pharma Patents – Key Insights & Stats (Updated 2023)

AlzeCure Pharma has a total of 87 patents globally, out of which 23 have been granted. Of these 87 patents, more than 73% patents are active. The United States of America is where AlzeCure Pharma has filed the maximum number of patents, followed by China. Parallelly, United Kingdom seems to be the main focused R&D centre and also Sweden is the origin country of AlzeCure Pharma. AlzeCure Pharma was founded in 2012. AlzeCure Pharma manufactures and distributes specialist medicinal products. The business provides medicine development and health research for Alzheimer’s disease and neuro restoration. Do read about some of the most popular patents of AlzeCure Pharma which have been covered by us in this article and also you can find AlzeCure Pharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over AlzeCure Pharma patent portfolio.

How many patents does AlzeCure Pharma have?

AlzeCure Pharma has a total of 87 patents globally. These patents belong to 15 unique patent families. Out of 87 patents, 64 patents are active.

How Many Patents did AlzeCure Pharma File Every Year?

AlzeCure Pharma Patent Filing Trend Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or Grant AlzeCure Pharma Applications Filed AlzeCure Pharma Patents Granted
2023 2 13
2022 5 4
2021 3 1
2020 17
2019 46
2017 9 3
2014 3
2012 1
2009 1 1
2006 1

 

How many AlzeCure Pharma patents are Alive/Dead?

Worldwide Patents AlzeCure Pharma Patent Portfolio

How Many Patents did AlzeCure Pharma File in Different Countries?

AlzeCure Pharma Worldwide Patent Filing

Countries in which AlzeCure Pharma Filed Patents

Country Patent
United States Of America 9
China 6
Europe 5
Hong Kong (S.A.R.) 5
Korea (South) 5
Canada 5
Brazil 5
Japan 5
India 4
Germany 3
Australia 3
South Africa 2
Austria 2
Italy 2
Mexico 2
Spain 2
United Kingdom 2
Israel 2
Poland 1
Chile 1
Singapore 1
Indonesia 1
Croatia 1
Lithuania 1
Portugal 1
Malta 1
Slovenia 1
Finland 1
Denmark 1
Malaysia 1
Norway 1

 

Where are Research Centers of AlzeCure Pharma Patents Located?

R&D Centres of AlzeCure Pharma

What are AlzeCure Pharma key innovation segments?

What Technologies are Covered by AlzeCure Pharma?

The chart below distributes patents filed by AlzeCure Pharma in different countries on the basis of the technology protected in patents. It also represents the markets where AlzeCure Pharmathinks it’s important to protect particular technology inventions.

R&D Focus: How has AlzeCure Pharma search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by AlzeCure Pharma?

     

Related Articles

Alphapharm Patents – Insights & Stats (Updated 2024)

Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be

Read More »

Complexa Patents – Insights & Stats (Updated 2024)

Complexa has a total of 77 patents globally, out of which 16 have been granted. Of these 77 patents, more than 22% patents are active. The United States of America is where Complexa has filed the maximum number of patents, followed by Japan. Parallelly, United States of America seems to

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.